Logo Logo
Hilfe
Hilfe
Switch Language to English

Burkhard-Meier, Anton; Remi, Constanze; Lindner, Lars H. und Bergwelt-Baildon, Michael von (2022): Cannabis in der Onkologie – viel Rauch um nichts? In: Deutsche Medizinische Wochenschrift, Bd. 147, Nr. 14: S. 916-922

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

The medical use of Cannabis has gained popularity in Europe and Northern America in recent years. Cannabinoids are available as finished pharmaceuticals, flowers and extracts. This article focuses on supportive medicine for oncological patients. Possible indications are pain, chemotherapy-induced nausea and vomiting, loss of appetite and altered taste perception. Despite the enormous cannabis hype in medicine, the evidence for its use in oncology patients is insufficient. However, palliative patients with refractory symptoms could be candidates for a therapeutic trial. The key parameter for choosing a cannabis medicinal product is the THC/CBD ratio. Oral forms of administration are particularly suitable for cannabis-naive and older patients. Mental and cardiovascular side effects should not be underestimated.

Dokument bearbeiten Dokument bearbeiten